These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4427254)

  • 1. Letter: Absolute drug bioavailability: approximation without comparison to parenteral dose for compounds exhibiting perturbable renal clearance.
    Lalka D; Feldman H
    J Pharm Sci; 1974 Nov; 63(11):1812. PubMed ID: 4427254
    [No Abstract]   [Full Text] [Related]  

  • 2. Absolute drug bioavailability II: Evaluation of renal clearance perturbation method using literature data assuring a fraction absorbed of unity.
    Lalka D; du Souich P; McLean AJ; Gibaldi M
    J Pharm Sci; 1978 Apr; 67(4):591-2. PubMed ID: 641784
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel method for bioavailability assessment.
    Kwan KC; Till AE
    J Pharm Sci; 1973 Sep; 62(9):1494-7. PubMed ID: 4743100
    [No Abstract]   [Full Text] [Related]  

  • 4. Individualized estimation of clearance following a loading dose and continuous intravenous infusion using a programmable calculator.
    Mitsuoka JC; Fleck RJ
    Comput Programs Biomed; 1983; 16(1-2):21-5. PubMed ID: 6687852
    [No Abstract]   [Full Text] [Related]  

  • 5. The significance of the arterial-venous plasma concentration difference in clearance studies.
    Chiou WL; Lam G
    Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):197-203. PubMed ID: 7095918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A safe method for rapidly achieving plasma concentration plateaus.
    Wagner JG
    Clin Pharmacol Ther; 1974 Oct; 16(4):691-700. PubMed ID: 4420442
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacokinetic models].
    Dahl S
    Tidsskr Nor Laegeforen; 1973 Jan; 93(3):157-62. PubMed ID: 4693373
    [No Abstract]   [Full Text] [Related]  

  • 8. [A pharmacokinetic function for galenics].
    Dost FH
    Arzneimittelforschung; 1971 May; 21(5):712-7. PubMed ID: 5109699
    [No Abstract]   [Full Text] [Related]  

  • 9. An overview of the analysis and interpretation of bioavailability studies in man.
    Wagner JG
    Pharmacology; 1972; 8(1):102-17. PubMed ID: 4644642
    [No Abstract]   [Full Text] [Related]  

  • 10. Method for the rapid estimation of the total body drug clearance and adjustment of dosage regimens in patients during a constant-rate intravenous infusion.
    Chiou WL; Gadalla MA; Peng GW
    J Pharmacokinet Biopharm; 1978 Apr; 6(2):135-51. PubMed ID: 671220
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioavailability of drugs (first of two parts).
    Koch-Weser J
    N Engl J Med; 1974 Aug; 291(5):233-7. PubMed ID: 4600408
    [No Abstract]   [Full Text] [Related]  

  • 12. Prediction of systemic availability from plasma-level data after oral drug administration.
    Perrier D; Gibaldi M; Boyes RN
    J Pharm Pharmacol; 1973 Mar; 25(3):256-7. PubMed ID: 4146327
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioavailability of drugs (second of two parts).
    Koch-Weser J
    N Engl J Med; 1974 Sep; 291(10):503-6. PubMed ID: 4604153
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioavailability under variable renal clearance conditions.
    Oie S; Jung D
    J Pharm Sci; 1979 Jan; 68(1):128-9. PubMed ID: 758455
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioavailability and pharmacokinetic analysis of drug responding systems.
    Smolen VF
    Annu Rev Pharmacol Toxicol; 1978; 18():495-522. PubMed ID: 348066
    [No Abstract]   [Full Text] [Related]  

  • 16. Periodicity during the distributive phase for drugs administered intravenously to humans.
    Wood JH; Lee AJ; Garrettson LK
    Drug Metab Rev; 1979; 9(1):119-28. PubMed ID: 446264
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapid attainment of successively higher steady-state plasma levels using the Wagner two-step infusion method.
    Zimmerman JJ
    J Pharm Sci; 1978 Dec; 67(12):1651-6. PubMed ID: 722475
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics and their clinical significance.
    Garrett ER
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jul; 2(3):193-6. PubMed ID: 5357862
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of first-pass effect on availability of drugs on oral administration.
    Gibaldi M; Boyes RN; Feldman S
    J Pharm Sci; 1971 Sep; 60(9):1338-40. PubMed ID: 5567579
    [No Abstract]   [Full Text] [Related]  

  • 20. An overview of the analysis and interpretation of bioavailability studies in man.
    Wagner JG
    Arzneimittelforschung; 1976; 26(1A):105-8. PubMed ID: 947190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.